← GoodRx Holdings, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.5m |
$388.2m
+55.59%
|
$550.7m
+41.85%
|
$745.4m
+35.36%
|
$766.6m
+2.83%
|
$750.3m
-2.12%
|
$792.3m
+5.61%
|
$796.9m
+0.57%
|
$785.2m
-1.46%
|
|
| Cost of revenue, exclusive of depreciation and amortization presented separately below | $6.0m |
$14.0m
+132.25%
|
$29.6m
+111.09%
|
$46.7m
+57.89%
|
$65.1m
+39.31%
|
$66.9m
+2.84%
|
$48.2m
-27.96%
|
$57.6m
+19.46%
|
$72.0m
+25.07%
|
|
| Gross Profit | $243.5m |
$374.2m
+53.69%
|
$521.1m
+39.26%
|
$698.7m
+34.08%
|
$701.5m
+0.40%
|
$683.3m
-2.59%
|
$744.1m
+8.89%
|
$739.3m
-0.65%
|
$713.2m
-3.53%
|
|
| Sales and marketing | $104.2m | $177.0m | $255.1m | $370.2m | $357.6m | $341.3m | $367.1m | $331.6m | — | |
| General and administrative | $8.4m | $14.7m | $461.5m | $154.7m | $144.8m | $125.5m | $117.9m | $114.0m | $107.6m | |
| Total costs and operating expenses | $172.3m | $248.5m | $826.4m | $732.0m | $764.8m | $777.3m | $726.5m | $709.4m | — | |
| Operating income (loss) | $77.3m |
$139.7m
+80.81%
|
($275.7m)
-297.40%
|
$13.4m
+104.86%
|
$1.7m
-87.04%
|
($27.0m)
-1653.91%
|
$65.8m
+343.81%
|
$87.5m
+32.87%
|
$74.9m
-14.34%
|
|
| Interest expense | $22.2m | $49.6m | $27.9m | $23.6m | ($34.2m) | ($56.7m) | ($52.9m) | ($42.6m) | $40.8m | |
| Interest income | ($154k) | ($715k) | ($160k) | ($59k) | $9.3m | $32.2m | $23.3m | $10.9m | $6.6m | |
| Other income (expense) | $7k | $3.0m | ($22k) | $0 | $0 | ($4.0m) | ($2.7m) | $718k | $649k | |
| Total other expense, net | $24.9m | $56.7m | $27.7m | $23.6m | ($25.0m) | ($28.6m) | ($34.4m) | ($31.0m) | — | |
| Income (loss) before income taxes | $52.3m | $83.0m | ($303.4m) | ($10.2m) | ($23.2m) | ($55.6m) | $31.5m | $56.5m | — | |
| Income tax (expense) benefit | ($8.6m) | ($16.9m) | $9.8m | ($15.1m) | ($9.6m) | $46.7m | ($15.1m) | ($26.1m) | $25.1m | |
| Net income (loss) | $43.8m |
$66.0m
+50.82%
|
($293.6m)
-544.56%
|
($25.3m)
+91.40%
|
($32.8m)
-29.99%
|
($8.9m)
+72.99%
|
$16.4m
+284.82%
|
$30.4m
+85.72%
|
$16.2m
-46.62%
|
|
| Basic (in usd per share) | $0.39 | $0.29 | ($1.07) | ($0.06) | ($0.08) | ($0.02) | $0.04 | $0.09 | — | |
| Diluted (in usd per share) | $0.37 | $0.29 | ($1.07) | ($0.06) | ($0.08) | ($0.02) | $0.04 | $0.09 | — | |
| Product development and technology | $43.9m | $29.3m | $61.8m | $125.9m | $143.1m | $135.8m | $123.7m | $121.0m | — | |
| Depreciation and amortization | $9.8m | $13.6m | $18.4m | $34.5m | $54.2m | $107.7m | $69.5m | $85.2m | $88.6m | |
| Loss on extinguishment of debt | $2.9m | $4.9m | $0 | $0 | $0 | $0 | ($2.1m) | $0 | — | |
| Total stock-based compensation | $1.8m | $3.7m | $397.3m | $160.5m | $120.2m | $104.8m | $99.0m | $76.6m | — |